Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Pain × Triamcinolone Acetonide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Uveal Melanoma 2 Lymphoma, T-Cell, Cutaneous 2 Lichen Planus, Oral 2 Stomach Neoplasms 1 Retinal Diseases 1 Radiodermatitis 1 Pain 1 Neuroma, Acoustic 1 Mycosis Fungoides 1 Melanoma 1 Macular Degeneration 1 Lymphomatoid Papulosis 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Follicular 1 Leiomyoma 1 Fibroma 1 Esophageal Stenosis Acquired 1 Dupuytren Contracture 1 Disease 1 Dermatitis, Contact 1 Choroid Diseases 1 Chalazion 1 Castration Resistant Prostate Cancer 1 Breast Neoplasms 1 Adenomyosis 1 Acute Gout 1

Interventions

Fentanyl 21 Analgesia 20 Morphine 17 Acupuncture Therapy 17 Zoledronic Acid 13 Acetaminophen 13 Oxycodone 12 Ketamine 12 Therapeutics 11 Lidocaine 11 Radiotherapy 10 Methadone 10 Ibandronic Acid 10 Hydromorphone 10 nabiximols 9 Ropivacaine 8 Bupivacaine 8 Surveys and Questionnaires 7 Psychiatric Rehabilitation 6 Early Intervention, Educational 6 Water 5 Tapentadol 5 Pregabalin 5 Music Therapy 5 Methods 5 Docetaxel 5 Cryotherapy 5 Cryosurgery 5 Control Groups 5 Analgesics, Opioid 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02025023 2020-02-06

CTS

University of Washington

Phase 3 Recruiting

Pain, Chalazion

Data powered by HemOnc (CC BY 4.0) Colophon ⚡